Establishment Labs Holdings Inc. (ESTA) stock
ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$69.51−0.31 (-0.44%)
Close on Nov 17, 2026Market cap $2.07BP/E –Yield –
Establishment Labs profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Establishment Labs's profit margin for the twelve months ending Sep 30, 2026 was -14.6%. For fiscal 2025 it was -24.2%, against -51.0% the year before. The highest annual figure on record is -24.2% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -24.2% | +26.8 |
| FY2024 | Dec 31, 2024 | -51.0% | −3.4 |
| FY2023 | Dec 31, 2023 | -47.5% | −1.0 |
| FY2022 | Dec 31, 2022 | -46.5% | −14.0 |
| FY2021 | Dec 31, 2021 | -32.5% | +12.5 |
| FY2020 | Dec 31, 2020 | -45.0% | −2.4 |
| FY2019 | Dec 31, 2019 | -42.6% | −8.1 |
| FY2018 | Dec 31, 2018 | -34.5% | +66.2 |
| FY2017 | Dec 31, 2017 | -100.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -14.9% | +5.8 |
| Q2 FY2026 | Jun 30, 2026 | -17.4% | +15.0 |
| Q1 FY2026 | Mar 31, 2026 | -22.3% | +27.7 |
| Q4 FY2025 | Dec 31, 2025 | -4.0% | +73.5 |
| Q3 FY2025 | Sep 30, 2025 | -20.7% | +20.7 |
| Q2 FY2025 | Jun 30, 2025 | -32.3% | +6.6 |
| Q1 FY2025 | Mar 31, 2025 | -50.1% | −6.5 |
| Q4 FY2024 | Dec 31, 2024 | -77.6% | −12.5 |
| Q3 FY2024 | Sep 30, 2024 | -41.5% | +34.6 |
| Q2 FY2024 | Jun 30, 2024 | -38.9% | −4.5 |
| Q1 FY2024 | Mar 31, 2024 | -43.6% | −17.9 |
| Q4 FY2023 | Dec 31, 2023 | -65.1% | −34.1 |
| Q3 FY2023 | Sep 30, 2023 | -76.0% | −27.4 |
| Q2 FY2023 | Jun 30, 2023 | -34.5% | +55.6 |
| Q1 FY2023 | Mar 31, 2023 | -25.7% | −10.2 |
| Q4 FY2022 | Dec 31, 2022 | -31.0% | +9.2 |
| Q3 FY2022 | Sep 30, 2022 | -48.7% | +1.9 |
| Q2 FY2022 | Jun 30, 2022 | -90.1% | −73.5 |
| Q1 FY2022 | Mar 31, 2022 | -15.4% | +7.5 |
| Q4 FY2021 | Dec 31, 2021 | -40.2% | −19.2 |
| Q3 FY2021 | Sep 30, 2021 | -50.5% | −31.9 |
| Q2 FY2021 | Jun 30, 2021 | -16.6% | +83.3 |
| Q1 FY2021 | Mar 31, 2021 | -22.9% | +49.6 |
| Q4 FY2020 | Dec 31, 2020 | -21.0% | +2.0 |
| Q3 FY2020 | Sep 30, 2020 | -18.7% | +37.2 |
| Q2 FY2020 | Jun 30, 2020 | -100.0% | −58.3 |
| Q1 FY2020 | Mar 31, 2020 | -72.5% | −20.6 |
| Q4 FY2019 | Dec 31, 2019 | -22.9% | +41.2 |
| Q3 FY2019 | Sep 30, 2019 | -55.9% | −63.9 |
| Q2 FY2019 | Jun 30, 2019 | -41.7% | −2.6 |
| Q1 FY2019 | Mar 31, 2019 | -51.9% | −7.8 |
| Q4 FY2018 | Dec 31, 2018 | -64.1% | −3.7 |
| Q3 FY2018 | Sep 30, 2018 | 8.0% | +153.8 |
| Q2 FY2018 | Jun 30, 2018 | -39.1% | +101.1 |
| Q1 FY2018 | Mar 31, 2018 | -44.1% | – |
| Q4 FY2017 | Dec 31, 2017 | -60.4% | – |
| Q3 FY2017 | Sep 30, 2017 | -145.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -140.2% | – |
See a number that looks wrong?